Prognostic implication of cellular DNA content in acute lymphoblastic leukemia. 1988

M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
Department of Pediatrics, Aichi Medical University, Japan.

To assess the prognostic value of the cellular DNA content measured by flow cytometry in acute lymphoblastic leukemia (ALL), we studied the pretreatment distribution of the DNA content in marrow blasts from 74 children with this disease. They were divided into standard- and high-risk groups according to their white blood cell counts and age at the time of diagnosis and were followed for up to 44 months. Abnormal DNA stemlines were detected in 26 children, and all of them had a hyperdiploid DNA content (DNA index of greater than 1.0). The duration of remission was significantly longer in those with hyperdiploid DNA stemlines than in those with diploid DNA stemlines in both risk groups. In the standard-risk group, the DNA content and common ALL antigen were significant prognostic factors, especially the former. In the high-risk group, the DNA content also showed an independent significant correlation with the clinical outcome.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
December 1987, The New England journal of medicine,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
May 1985, Blood,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
October 1990, Cancer,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
September 2018, Clinical laboratory,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
August 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
December 2011, Hematology/oncology clinics of North America,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
August 2009, Current opinion in molecular therapeutics,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
November 1992, Leukemia,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
January 2000, Journal of pediatric hematology/oncology,
M Tsurusawa, and N Katano, and S Kawai, and T Fujimoto, and M Maeda
May 2006, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!